-
Google PR 3Trustworthiness Good
-
Avg. Daily Visitors N/AChild Safety Unknown
-
Avg. Daily Pageviews N/APrivacy Good
Dermaliq Therapeutics Announces First Patient Dosed in Phase 1b/2 Trial Evaluati...
Domain info
Location: | Germany |
Hosted by: | 1&1 IONOS SE |
Registrar: | DENIC eG |
Subnetworks: | 217.160.0.203 |
Social Media Activities
- Facebook likes: -
- Twitter mentions: 1
- Google pluses: -
- LinkedIn mentions: -
- Pinterest pins: -
- StumbleUpon views: -
Web Safety
- This website is malware-free.
- Status ok
Whois
Novaliq.de popular pages to visit
Dermaliq Therapeutics Announces First Patient Dosed in Phase 1b/2 Trial Evaluating DLQ02 for Treatment of Plaque Psoriasis
Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first and only water-free technology worldwi...
Dermaliq Therapeutics Announces First Patient Dosed in Phase 1b/2 Trial Evaluating DLQ02 for Treatment of Plaque Psoriasis
Dermaliq Therapeutics Announces First Patient Dosed in Phase 1b/2 Trial Evaluating DLQ02 for Treatment of Plaque Psoriasis
Wilmington, Delaware, August 18, 2022 – Dermaliq Therapeutics, Inc. (Derm...
Dermatology - Novaliq
Dermatology
The Skin is our largest organ
The skin is unique in many ways, but no other organ is so visible and demands so much attention and care in both diseased and healthy states
Skin ...